Finance

Beta
Lists
COGT:NASDAQ
Cogent Biosciences Inc
$33.20
-4.63%
(-1.61) 1D
Jun 2, 2:15:17 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COGT...
Open
$34.33
High
$34.56
Low
$31.32
Mkt. cap
5.67B
Avg. vol.
1.78M
Volume
2.67M
52-wk high
$43.73
52-wk low
$5.41
EPS
-$2.15
Beta
0.34
Shares outstanding
170.87M
No. of employees
258
Open
$34.33
High
$34.56
Low
$31.32
Mkt. cap
5.67B
Avg. vol.
1.78M
Volume
2.67M
52-wk high
$43.73
52-wk low
$5.41
EPS
-$2.15
Beta
0.34
Shares outstanding
170.87M
No. of employees
258
News stories
From sources across the web
About Cogent Biosciences Inc
CEO-
Employees258
Founded2014
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitecogentbio.com
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.53 / -$0.54
+1.88%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
62.20M
68.99M
75.56M
75.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.38M
14.37M
23.93M
28.24M
Operating expense
75.58M
83.36M
99.49M
103.61M
Total operating expenses
75.58M
83.36M
99.49M
103.61M
Operating income
-75.58M
-83.36M
-99.49M
-103.61M
Other non operating income
-6.00K
-3.00K
900.00K
-140.00K
EBT including unusual items
-73.53M
-80.93M
-102.49M
-97.35M
EBT excluding unusual items
-73.53M
-80.93M
-94.40M
-97.35M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-73.53M
-80.93M
-102.49M
-97.35M
Net profit margin
-
-
-
-
Earnings per share
-0.53
-0.50
-0.56
-0.53
Interest and investment income
2.37M
3.89M
5.48M
7.61M
Interest expense
-314.00K
-1.46M
-1.29M
-1.21M
Net interest expenses
2.06M
2.43M
4.19M
6.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
-74.93M
-82.71M
-98.86M
-102.98M
Gain or loss from assets sale
-
-
-
135.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer